Skip to content

Polyflex Epicardial 439-04 Implant Pacing Lead

by Intermedics, Inc.

510(k) K874531

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK874531 Date7 Jan 1988ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Polyflex(R) Epicardial 439-04 Implant Pacing Lead
510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Polyflex Epicardial 439-04 Implant Pacing Lead is a permanent pacemaker electrode designed for epicardial placement. It delivers electrical stimulation to regulate heart rhythm in patients requiring cardiac pacing, typically those with bradycardia or conduction system disorders.

This lead is intended for surgical implantation during open-chest procedures, where it is positioned on the epicardial surface of the heart. Supplied sterile and intended for single-use, it is classified as a Class III medical device under FDA regulations. The device is authorized through an FDA 510(k) clearance (K874531) and adheres to the regulatory requirements outlined in 21 CFR 870.3680.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of patients is this epicardial pacing lead designed for, and how is it implanted?

    This lead is designed for patients requiring cardiac pacing due to bradycardia or conduction system disorders. It is intended for surgical implantation during open-chest procedures, where it is positioned on the epicardial surface of the heart to deliver electrical stimulation and regulate heart rhythm.

  • Is the Polyflex Epicardial 439-04 Implant Pacing Lead reusable or single-use, and how is it supplied?

    The lead is supplied sterile and intended for single-use only. It comes pre-packaged for immediate surgical use, ensuring sterility and minimizing risk of contamination.

  • What regulatory pathway was followed for FDA clearance of this device, and what class does it fall under?

    The Polyflex Epicardial 439-04 Implant Pacing Lead received FDA 510(k) clearance (K874531) under the traditional review pathway, with a decision of *Substantially Equivalent* (SESE). It is classified as a Class III medical device under FDA regulations, reflecting its role in life-sustaining or life-supporting functions.

  • How is this lead differentiated from other permanent pacemaker electrodes, and what surgical context is it intended for?

    This lead is specifically designed for epicardial placement, meaning it is surgically positioned on the outer surface of the heart during open-chest procedures. Unlike transvenous leads, it requires direct access to the heart tissue, making it suitable for cases where epicardial pacing is clinically indicated, such as in congenital heart disease or certain arrhythmias.